Prostate drug, abiraterone, to be offered to thousands in England - BBC
Google News • 1/16/2026 – 1/17/2026
Summary
The NHS is expanding access to the prostate cancer drug abiraterone in England, aiming to save thousands of lives. The drug, which costs £2.50, will be offered to thousands of men with prostate cancer.
Advertisement
Lindy Score Breakdown (V4.2)
100d
Age
1
Sources
from cluster
2386
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^2386/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^2386/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 100 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Sanofi MS drug gets positive review in Europe following FDA
Stat News • 2 days ago
Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
Stat News • 1 day ago
Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs
Stat News • 1 day ago
STAT+: FDA to speed up review of three psychedelics as mental health treatments
Stat News • 2 days ago
Opinion: The local news crisis is also a public health crisis
Stat News • 2 days ago
STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment
Stat News • 2 days ago
International childhood vaccine campaign grows
Stat News • 2 days ago
STAT+: Up and Down the Ladder: The latest comings and goings
Stat News • 2 days ago
Opinion: I started medical school at 69 and will begin residency at 72. Here’s what I learned
Stat News • 2 days ago
STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
Stat News • 2 days ago
